gamma-fluoromethotrexate

Known as: FMTX 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2010
012319852010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The importance of intracellular folate metabolism is illustrated by the severity of symptoms and complications caused by inborn… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
2010
2010
The two organic anion transporting polypeptides (OATPs) 1B1 and 1B3 are expressed at the sinusoidal membrane of hepatocytes. They… (More)
  • table 1
  • table 2
Is this relevant?
2005
2005
The reduced-folate carrier (Rfc-1), previously also called methotrexate carrier-1 (MTX-1), was recently identified as accounting… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
PURPOSE Studies in oncology have implicated multiple molecular mechanisms as contributors to intrinsic and acquired tumor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2003
2003
The synthesis and characterization of 3'-fluoromethotrexate (FMTX), a novel fluorine-labeled analogue of methotrexate, are… (More)
Is this relevant?
1998
1998
The objective of this phase I-II study was to determine the efficacy and toxicity of combination chemotherapy with 5-fluorouracil… (More)
Is this relevant?
1996
1996
We analyzed the clinical response, toxicities, out-patient and overall survival time among 41 gastric cancer patients with… (More)
Is this relevant?
1989
1989
We previously reported (J. Galivan et al., Proc. Natl. Acad. Sci. USA, 82: 2598-2602, 1985) the synthesis and characterization of… (More)
Is this relevant?
1989
1989
Gamma-fluoromethotrexate (FMTX) is a poorly glutamylated mimic of the anti-cancer drug methotrexate (MTX) which is useful in… (More)
Is this relevant?
1985
1985
A methotrexate (MTX) analog containing fluorine at the gamma-carbon of the glutamate moiety, gamma-fluoromethotrexate (FMTX), has… (More)
Is this relevant?